RACHEL BROWN: Open Payments
NPI 1760126361 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 79 payments from 20 companies in 2025. Trend: 2023 $1,821 · 2024 $1,629 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $207 |
| Abbott Laboratories | 10 | $183 |
| PFIZER INC. | 13 | $170 |
| AstraZeneca Pharmaceuticals LP | 3 | $148 |
| Lilly USA, LLC | 7 | $100 |
| Amgen Inc. | 6 | $94 |
| Phathom Pharmaceuticals, Inc. | 7 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: FREESTYLE LIBRE, NURTEC ODT, FARXIGA, UBRELVY, MOUNJARO, OTEZLA, VOQUEZNA, QULIPTA.
Industry payments across TX — which companies pay providers there.
